Reply to "SARS-CoV-2 reinfection or persistence among immunodeficient patients".

Marcus-Mandelblit, Nufar; Ashkenazi-Hoffnung, Liat; Scheuerman, Oded

Marcus-Mandelblit, Nufar; Ashkenazi-Hoffnung, Liat; Scheuerman, Oded.

Marcus-Mandelblit N; Schneider Children's Medical Center of Israel, Kipper Institute of Immunology, Petah Tikva, Israel. Electronic address: nufarmar@gmail.com.
Ashkenazi-Hoffnung L; Department of Day Hospitalization, Pediatric Infectious Disease Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Scheuerman O; Pediatrics B, Pediatric Infectious Disease Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

J Allergy Clin Immunol Pract ; 11(3): 972-973, 2023 03.

Article in English | MEDLINE | ID: covidwho-2270816

Subject(s)

COVID-19; Humans; Reinfection; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: J Allergy Clin Immunol Pract Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google